Clinical Trials

Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1
  • Intervention Type: Drug
  • Participants: 66
  • Start Date: August 29, 2020
An Open-Label, Multicenter Study To Investigate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of RO7248824 In Participants With Angelman Syndrome
Clinical Trial
  • Status: Active, not recruiting
  • Phase: Phase 1/Phase 2
  • Intervention Type: Drug
  • Participants: 20
  • Start Date: February 24, 2020
A Phase 1/2 Open-label, Multiple-dose, Dose-escalating Clinical Trial of the Safety and Tolerability of GTX-102 in Pediatric Patients With Angelman Syndrome (AS)
Search for trials
Clinical Trial
  • Status: Recruiting
  • Phase: Early Phase 1
  • Intervention Type: Procedure
  • Participants: 30
  • Start Date: December 18, 2019
A Study to Explore Cerebrospinal Fluid and Blood Biomarkers in Participants With Angelman Syndrome
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 82
  • Start Date: February 25, 2019
An Open-Label Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of OV101 in Individuals With Angelman Syndrome
Clinical Trial
  • Status: Recruiting
  • Participants: 150
  • Start Date: August 1, 2018
Angelman Syndrome Natural History Study
Clinical Trial
  • Status: Active, not recruiting
  • Participants: 100
  • Start Date: February 16, 2018
Italian Angelman Syndrome Registry Protocol
Showing 1-6 of 6